Diastolic Heart Failure in Patients With the Fontan Circulation: A Review

Werner Budts1, William J Ravekes2, David A Danford3

  • 1University Hospitals Leuven, Congenital and Structural Cardiology, Catholic University of Leuven, Leuven, Belgium.

JAMA Cardiology
|February 6, 2020
PubMed

Insights

Diastolic dysfunction is an underrecognized cause of Fontan circulation failure in single-ventricle patients. Early detection and novel therapies are crucial for improving outcomes in this complex congenital heart condition.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Pediatric Cardiac Surgery

Background:

  • The Fontan circulation surgically connects vena cavae to pulmonary arteries for single-ventricle palliation.
  • Fontan circulation failure can stem from mechanical issues, arrhythmias, pulmonary resistance, or ventricular decline.
  • Systolic dysfunction is recognized, but diastolic dysfunction is an underappreciated cause of Fontan failure.

Purpose of the Study:

  • To highlight the significance of diastolic ventricular dysfunction in Fontan circulation failure.
  • To discuss the challenges and evolving methods for diagnosing diastolic dysfunction in single ventricles.
  • To explore current and future therapeutic strategies for managing diastolic dysfunction in Fontan patients.

Main Methods:

  • Review of existing literature on Fontan circulation physiology and failure modes.
  • Discussion of diagnostic challenges for diastolic dysfunction in single-ventricle physiology.
  • Exploration of potential diagnostic advancements combining biomarkers, imaging, and invasive data.

Main Results:

  • Diastolic ventricular dysfunction is likely underdiagnosed in Fontan circulation.
  • Current diagnostic techniques for biventricular hearts lack validation in single ventricles.
  • Biomarkers, cardiac MRI, and echocardiography combined with pressure-volume data show promise for diagnosis.

Conclusions:

  • Accurate, noninvasive diagnosis of diastolic dysfunction is critical for Fontan circulation management.
  • Therapies for severe diastolic dysfunction are often limited, potentially necessitating advanced interventions like ventricular assist devices or transplantation.
  • Improving Fontan palliation outcomes requires innovation in prevention and pharmacotherapy.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
603
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
166
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
312
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
262
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
248
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K